Successful treatment with an anti-PD-1 antibody for progressing brain metastases in renal cell cancer
Related Experiment Video
Updated: Mar 29, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.4K
C Rothermundt1, C Hader2, S Gillessen3
1Department of Oncology/Haematology, Kantonsspital St Gallen, St Gallen, Switzerland christian.rothermundt@kssg.ch.
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

